Evidence map›Paper›PMID 39621693›Full record

ArticlePloS one2024

Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.

Saeid Rasouli, Mohammad Sedigh Dakkali, Azim Ghazvini, Reza Azarbad, Mahdi Asani, Zahra Mirzaasgari, Mohammed Arish

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saeid RasouliFive Senses Health Research Institute, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Mohammad Sedigh DakkaliDepartment of Ophthalmology, School of Medicine, Al Zahra Eye Hospital, Zahedan University of Medical Sciences, Zahedan, Iran.
Azim GhazviniSchool of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Reza AzarbadHealth Research Institute, Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-8238-5404
Mahdi AsaniDepartment of Ophthalmology, School of Medicine, Al Zahra Eye Hospital, Zahedan University of Medical Sciences, Zahedan, Iran.
Zahra MirzaasgariDepartment of Neurology, Firoozgar Hospital, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Mohammed ArishDepartment of Ophthalmology, School of Medicine, Al Zahra Eye Hospital, Zahedan University of Medical Sciences, Zahedan, Iran.ORCID 0000-0002-9208-0911

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOptic neuritis (ON) can be an initial clinical presentation of multiple sclerosis This study aims to provide a practical predictive model for identifying at-risk ON patients in developing MS.

methodWe utilized data from the Optic Neuritis Treatment Trial study, which enrolled 457 patients aged from 18 to 46 years, all diagnosed with acute ON. These patients underwent up to 15 years of neurological and ophthalmologic examinations and imaging. The selection of variables for the developing model was based on clinical importance and statistical significance, and any missing values were appropriately addressed. We developed a Decision Tree (DT) classifier as the primary model and manually tuned its hyperparameters for optimal performance. We employed SHapley Additive exPlanations (SHAP) for feature importance evaluation. All analysis was performed using Python version 3.10.9 and its associated libraries.

resultsA total of 388 patients completed the study, of which 154 developed clinically definite multiple sclerosis (CDMS). It was observed that 61% of patients with magnetic resonance imaging (MRI) lesions developed CDMS. The final variables selected for analysis were MRI lesions, neurologic history, ON type, gender, and visual field mean deviation. The DT model achieved an accuracy of 70.1% during cross-validation and 69.1% on the test set, with an area under the curve of 74.9% and 71.7%, respectively. Comparative analysis of DT with other models showed similar performance. SHAP analysis revealed that MRI lesions and ON type emerged as the two most significant features, with relative importance of 61% and 18%, respectively.

conclusionThe decision tree model, with satisfactory performance, effectively stratifies patients, based on baseline findings and offers valuable insights for informed decision-making by physicians.

Indexed as

Decision TreesMagnetic Resonance ImagingMultiple SclerosisOptic NeuritisAdolescentAdultFemaleHumansMaleMiddle AgedYoung Adult

Identifiers

PMID39621693
PMCPMC11611084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.